Brendan McDonnell Net Worth & Insider Trades
Brendan McDonnell - Director, Hollis Eden Pharmaceuticals Inc
What is Brendan McDonnell's Net Worth?
The current estimated net worth of Hollis Eden Pharmaceuticals Inc's Director, Brendan McDonnell, is estimated to be about $250.79K . Brendan McDonnell owns about 10,000 units of Hollis Eden Pharmaceuticals Inc common stock. In the last 4 years at Hollis Eden Pharmaceuticals Inc, Brendan McDonnell has sold an estimated value of $193.75K worth.
What is Brendan McDonnell's Past Insider Trading?
Brendan McDonnell's largest purchase order was 10,000 units , worth over $57.04K on December 12, 2006. Brendan McDonnell's largest sale order was 5,000 units , worth over $44.73K on August 10, 2005. In total, Brendan McDonnell has made about 12 transactions over 4 years of their time at Hollis Eden Pharmaceuticals Inc. Brendan McDonnell usually trades in January, with the busiest year in 2006.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BRENDAN MCDONNELL
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Brendan McDonnell's' Mailing Address?
- Mailing address is C/o Hollis-Eden Pharmaceuticals 4435 Eastgate Mall Ste.400 San Diego CA 92121 CA
What are Hollis Eden Pharmaceuticals Inc's Past Insider Trades?
Hollis Eden Pharmaceuticals Inc's most recent insider trade came on March 5, 2007 by Robert Weber who sold 3,000 units worth $15.93K . In the last 4 years, insiders at Hollis Eden Pharmaceuticals Inc have sold an estimated value of $4.6M and bought an estimated value of $292.73K worth of shares. Insider trading is most common in February, with the busiest year in 2006. The most active traders at the company are Robert W Weber, Chief Financial Officer, Brendan McDonnell, Director, and Christopher Reading, Chief Scientific Officer .
HOLLIS EDEN PHARMACEUTICALS INC /DE/ Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |